Hesperos’ Human-on-a-Chip® technology earns recognition in a Nature Lab Animal article highlighting advancements in human-relevant, new alternative methods (NAMs) models and publishes new research advancing its sarcopenia-on-a-chip system.
Hesperos and Bayer unveil the first Human-on-a-Chip® model replicating stress-induced cognitive decline to advance non-animal CNS drug research.
The FDA Modernization Act 2.0 was signed into law eliminating the animal testing mandate in drug discovery.
Hesperos Chief Scientist, Dr. James Hickman, awarded Researcher of the Year at the 2022 BioFlorida conference in Miami
In a recent study published in Biomaterials, a team of researchers led by Hesperos Chief Scientist Dr. J. Hickman established a significant finding to better understand ALS etiology and potential new treatment targets.